Jounce Therapeutics Inc (JNCE) leads the Biotechnology industry with an overall score of 98. JNCE is up 127.88% so far this year after the company closed yesterday at $8.5. The overall score measures the company's performance based-off both short and long term indicators and means that JNCE scores better than 98% of the overall market.
Jounce Therapeutics Inc is a strong performer in the Biotechnology industry, which has an average overall score of 47. This means that, on average, the stocks in this industry score higher than 47% of the stock market.
To see InvestorsObserver's Sentiment Score for Jounce Therapeutics Inc click here.
JNCE has been trading neutral recently. The stock is trading down -10.99% this week following yesterday's rise. JNCE has an average analyst ranking of Buy with an average price target of $19.
Click Here to get the full Stock Score Report on Jounce Therapeutics Inc (JNCE) Stock.